Effect of Raised Head of the Bed on Lying Blood Pressure in Autonomic Failure
Impact of Decreased Venous Return on Supine Blood Pressure
1 other identifier
interventional
44
1 country
1
Brief Summary
Many persons with autonomic failure often have high blood pressure when lying down (supine hypertension). This study is exploring the impact of decreased venous return to the heart (achieved by raising the head of the bed) to lessen supine blood pressure. If decreased venous return to the heart is effective at lowering supine blood pressure, these approaches may be utilized to treat supine hypertension non-pharmacologically. Raising the head of the bed decreases the amount of blood returning to the heart due to the effects of gravity. In this case, the decreased blood return to the heart may decrease blood pressure.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Aug 2020
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 20, 2020
CompletedFirst Posted
Study publicly available on registry
August 6, 2020
CompletedStudy Start
First participant enrolled
August 21, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 31, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 31, 2026
November 6, 2025
November 1, 2025
6 years
July 20, 2020
November 4, 2025
Conditions
Outcome Measures
Primary Outcomes (2)
Systolic Blood Pressure
Maximal change from baseline in systolic blood pressure during the night
10 PM to 8 AM
Systolic Blood Pressure
Difference in systolic blood pressure between tilt and elevated trunk sessions
10 PM to 8 AM or acute session (1 hour at each elevation of the head)
Secondary Outcomes (1)
Overnight Urine Volume
10 PM to 8 AM
Study Arms (4)
Elevation of the whole bed (tilt)
EXPERIMENTALTilt of the whole bed so that the participant's head is raised by 9 and/or 12 inches.
Elevation of the trunk
EXPERIMENTALElevation of the trunk by tilting just the head of the bed so that the participant's head is raised by 9 and/or 12 inches.
Elevation of the whole bed (tilt) - In home
EXPERIMENTALTilt of the whole bed so that the participant's head is raised by 8 inches.
Elevation of the trunk - In home
EXPERIMENTALElevation of the trunk by raising the head 8 inches on a wedge pillow.
Interventions
Tilt of the whole bed so that the head is elevated by 9 and/or 12 inches in an acute trial or overnight.
Elevation of the trunk through raising just the head of the bed until the head is elevated by 9 and/or 12 inches in an acute trial or overnight.
Tilt of the whole bed so that the head is elevated by 8 inches overnight.
Elevation of the trunk through raising the head 8 inches on a wedge pillow overnight.
Eligibility Criteria
You may qualify if:
- Patients with autonomic failure and with supine hypertension from all races
- Males and females, between 18 to 85 years
You may not qualify if:
- All medical students
- Pregnant women
- High-risk patients (for example: heart failure, symptomatic coronary artery disease, liver impairment, history of stroke or myocardial infarction)
- History of serious allergies or asthma.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Vanderbilt University Medical Center
Nashville, Tennessee, 37232, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Italo Biaggioni, MD
Vanderbilt University Medical Center
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor of Medicine and Pharmacology
Study Record Dates
First Submitted
July 20, 2020
First Posted
August 6, 2020
Study Start
August 21, 2020
Primary Completion (Estimated)
August 31, 2026
Study Completion (Estimated)
December 31, 2026
Last Updated
November 6, 2025
Record last verified: 2025-11
Data Sharing
- IPD Sharing
- Will not share